3D Global Biotech Balance Sheet Health
Financial Health criteria checks 6/6
3D Global Biotech has a total shareholder equity of NT$293.5M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$324.1M and NT$30.7M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$166.02m |
Equity | NT$293.47m |
Total liabilities | NT$30.68m |
Total assets | NT$324.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6808's short term assets (NT$175.7M) exceed its short term liabilities (NT$26.5M).
Long Term Liabilities: 6808's short term assets (NT$175.7M) exceed its long term liabilities (NT$4.2M).
Debt to Equity History and Analysis
Debt Level: 6808 is debt free.
Reducing Debt: 6808 has no debt compared to 5 years ago when its debt to equity ratio was 1.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6808 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6808 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 4.7% each year